It's actually getting to be quite impressive how Angelo can be bothered with all these rows on different threads on an internet forum. He is going to need to give a man a start or employ a secretary to keep up with it all. Serious effort.
It looks that way at first.
Then you realise that every post on a topic is just a clone of the previous one - Big Pharma! Big Pharma! Big Pharma!
Sometimes it seems like a standard trolling exercise, other times you'd worry about him.
He has a point though - some serious profiteering going on here. Prof Ugur Sahin, BioNTech co-founder on the Andrew Marr show had no answer to how long immunity would last, or if it would stop transmission yet we have lads on here queuing up to get it. One question no one is answering (maybe they did but I can't be arsed reading back through the pages I have missed) is surely it is against the human rights of Care Home residents to have this forced upon them especially as the usual 10 year vaccine has been rushed through in 10 months, and if there is side effects and these poor souls die would anyone care, they seem to be collateral damage.
The reason there is rush is because it is impacting the world's economy at billion dollar levels and killing people at levels of millions.
Therefore there is money to be made. So this is why is worthwhile for companies to put the investment in to take a chance on a new kind of vaccine (mRNA). This allows for the faster development.
https://www.wired.com/story/why-its-a-big-deal-if-the-first-covid-vaccine-is-genetic/"Since small companies like BioNTech, Moderna, and Inovio began developing genetic vaccines about 10 years ago, that speed has always been the brightest of its promises. The faster you can make and test vaccines, the faster you can respond to outbreaks of new diseases. But with any novel approach comes risk—risks that the vaccine won’t work well or, worse, that it harms someone, and millions of dollars will be wasted on a technology that turns out to be a flop. Until this year, major vaccine developers had shied away from genetic vaccines. Before 2020, only 12 mRNA vaccines ever made it to human trials. None were approved. Then came the coronavirus.
“Before the pandemic, there weren’t the financial incentives or the opportunities for the big pharmaceutical companies to get involved,” says Peter Hotez, a vaccine researcher and dean of the National School of Tropical Medicine at Baylor College of Medicine.
Now you have 2 different companies posting similar results with a similar method - that at least demonstrates repeatability.
Show Posts
